Page 3 - Diagnostics Pillar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Fund Thanks the United States for US$3.5 Billion Emergency Investment to Fight COVID-19 Format GENEVA – The Global Fund applauds the U.S. government for approving US$3.5 billion in emergency funding for the Global Fund’s effort to fight the COVID-19 pandemic in low- and middle-income countries. This unprecedented support will rapidly accelerate the Global Fund’s response to the pandemic, which is critical to save lives and protect the gains our partnership has made against HIV, TB and malaria over the last two decades. In the last year, COVID-19 has caused widespread disruption t...

11 March 2021 GENEVA – The Global Fund applauds the U.S. government for approving US$3.5 billion in emergency funding for the Global Fund’s effort to fight the COVID-19 pandemic in low- and middle-income countries. This unprecedented support will rapidly accelerate the Global Fund’s response to the pandemic, which is critical to save lives and protect the gains our partnership has made against HIV, TB and malaria over the last two decades. In the last year, COVID-19 has caused widespread disruption to HIV, TB and malaria service delivery. The Global Fund’s COVID-19 response is mitiga...

(2) Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development NEW YORK, Jan. 28, 2021 /PRNewswire/ -- The public-private initiatives that contributed to COVID-19 vaccine and drug development have showcased a model for accelerating biomedical innovation. However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit. Over the last decade, such alliances have produced a wide assortment of life-saving technologies targeting diseases that a...